title: [Occurrence of markers, distribution of genotypes and risk factors for viral hepatitis C among some groups of the population in the Novosibirsk region].
abstract: The occurrence of markers, genotypic variability of isolates and risk factors for viral hepatitis C (HCV) were studied in 4 groups of residents of the Novosibirsk region (altogether 2,000 persons). Anti-HCV IgG were detected within the range from 4.6% among medical personnel to 48% among the patients of the drug-abuse clinic. The detection rate of HCV RNA in seropositive samples varied from 79.3% to 86.3%. The determination of genotype was carried out for 388 isolates: 1b--50.3%, 2a--4.4%, 2c--0.3%, 3a--44.8%. The highest risk indices with respect to HCV among the residents of the region were linked with the drug use (OR=77.5; p<0.05) as well as with risky behavior and low social status. The elevated numbers of seropositive persons were detected among unemployed (OR=16.3), alcohol abusers (OR=3.9), persons having more than 4 sex partners in their lifetime (OR=4.3) and persons having homosexual contacts (OR=6.6). In some groups blood transfusions also played a definite role in the transmission of HCV. In the analysis, carried out separately for two different genotypes the intravenous use of drugs was perceptibly stronger linked with VHC of genotype 3 (OR=85.5) in comparison with HCV of genotype 1 (OR=49.3) and genotype 2 (OR=41.1). Genotype 1 prevailed in the older age group and genotype 3, among young people.
authors.forename: A V
authors.initials: AV
authors.lastname: Shustov
authors.forename: G V
authors.initials: GV
authors.lastname: Kochneva
authors.forename: G F
authors.initials: GF
authors.lastname: Sivolobova
authors.forename: A A
authors.initials: AA
authors.lastname: Grazhdantseva
authors.forename: I V
authors.initials: IV
authors.lastname: Gavrilova
authors.forename: L A
authors.initials: LA
authors.lastname: Akinfeeva
authors.forename: I G
authors.initials: IG
authors.lastname: Rakova
authors.forename: M V
authors.initials: MV
authors.lastname: Aleshina
authors.forename: V N
authors.initials: VN
authors.lastname: Bukin
authors.forename: V G
authors.initials: VG
authors.lastname: Orlovskiĭ
authors.forename: V S
authors.initials: VS
authors.lastname: Bespalov
authors.forename: A P
authors.initials: AP
authors.lastname: Zelicoff
authors.forename: S V
authors.initials: SV
authors.lastname: Netesov
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D016174:Hepacivirus / Q000235:genetics / Q000302:isolation & purification*; D006526:Hepatitis C / Q000097:blood / Q000453:epidemiology* / Q000635:transmission; D018937:Hepatitis C Antibodies / Q000097:blood; D006801:Humans; D008297:Male; D008875:Middle Aged; D012367:RNA, Viral / Q000097:blood; D012307:Risk Factors; D012424:Rural Population; D012800:Siberia / Q000453:epidemiology; D012959:Socioeconomic Factors; D015819:Substance Abuse, Intravenous / Q000097:blood / Q000453:epidemiology / Q000382:microbiology
chemical_list: D018937:Hepatitis C Antibodies; D012367:RNA, Viral